Kidney Research for Better Outcomes
Research into better ways to treat kidney disease is at the center of our nephrology care. As part of a leading academic medical center, our physicians are continually participating in and conducting significant research into kidney disease and kidney cancer. Clinical research helps advance our understanding of these diseases and how to treat them, and clinical trials can make advanced treatments available to patients sooner. It all adds up to expert care and better outcomes for our patients.
Ask your doctor if participating in a clinical trial is appropriate for you.
View current kidney cancer clinical trials
You can also learn more about clinical trials at ClinicalTrials.gov.
A Strong History of Best Practices in Nephrology
We have a long history of studying kidney disease and uncovering new understanding of the disease and how best to treat it.
In the 1960s, Jacob Lemann, Jr., MD, and Edward Lennon, MD, conducted clinical studies at Milwaukee County Hospital (which later merged with Froedtert Hospital), and proved that metabolic acidosis caused bone mineral loss. Metabolic acidosis can occur when the kidneys don’t remove enough acid from the blood.
In the 1970s, Dr. Lemann established a technique to show that chronic kidney disease is often progressive, a technique that remains in use and has had a significant impact on improved patient care.
In studies that started in the 1990s, Eric Cohen, MD, Medical College of Wisconsin nephrologist, and his colleagues defined the occurrence of chronic kidney failure after hematopoietic stem cell transplant, a procedure sometimes used to treat certain types of cancer. His research led to better understanding of ways to treat and prevent chronic kidney disease in patients who undergo hematopoietic stem cell transplant.